Cancer drugs

Cancer drugs

Drugs, agents used in the treatment of cancer or conditions related to cancer.

Industry: Pharmaceutical

Add a new term

Contributors in Cancer drugs

Become a Contributors

Cancer drugs

Iodine I 123 anti-CEA recombinant diabody T84.66

Pharmaceutical; Cancer drugs

A radioimmunoconjugate comprised of a recombinant scFv dimer diabody of a monoclonal antibody against human carcinoembryonic antigen (CEA) labelled with iodine I 123 (I-123) with potential ...

Yttrium Y 90 anti-CEA monoclonal antibody cT84.66

A radioimmunoconjugate comprised of a chimeric monoclonal antibody against human carcinoembryonic antigen (CEA) conjugated with the radioisotope yttrium 90 (Y-90) via the chelator tetra-azacyclododeca ...

18F-fluoroazomycin arabinoside

Pharmaceutical; Cancer drugs

A radiofluorinated 2-nitroimidazole derivative with hypoxia-specific tracer activity. 18F-fluoroazomycin arabinoside is reduced under hypoxic conditions and is often seen in various malignant tumors, ...

18F-fluoromisonidazole

Pharmaceutical; Cancer drugs

A radiofluorinated 2-nitroimidazole derivate with hypoxia-specific tracer activity. Misonidazole is reduced under hypoxic conditions and in reduced form covalently binds to macromolecules in hypoxic ...

Yttrium Y 90 DOTA-biotin

Pharmaceutical; Cancer drugs

A radioconjugate of biotin and yttrium Y 90 (Y-90) linked through the bifunctional macrocyclic chelating agent tetra-azacyclododecanetetra-acetic acid (DOTA) with radioimmunotherapy property. Biotin ...

Iodine I 124

Pharmaceutical; Cancer drugs

A radioactive isotope of iodine, a nonmetallic element of the halogen group, with an atomic mass of 124 and a half-life of 4. 18 days with radioisotopic activity. Selectively accumulating in thyroid ...

Iodine I 125

Pharmaceutical; Cancer drugs

A radioactive isotope of iodine, a nonmetallic element of the halogen group. With a half-life of 60 days, iodine 125 occurs naturally and can be produced artificially. This agent has both therapeutic ...